HomeCompareNAUBF vs MRK

NAUBF vs MRK: Dividend Comparison 2026

NAUBF yields 3.41% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NAUBF wins by $790.32M in total portfolio value
10 years
NAUBF
NAUBF
● Live price
3.41%
Share price
$32.14
Annual div
$1.10
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$790.38M
Annual income
$748,253,843.62
Full NAUBF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — NAUBF vs MRK

📍 NAUBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNAUBFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NAUBF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NAUBF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NAUBF
Annual income on $10K today (after 15% tax)
$290.06/yr
After 10yr DRIP, annual income (after tax)
$636,015,767.08/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, NAUBF beats the other by $636,007,438.67/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NAUBF + MRK for your $10,000?

NAUBF: 50%MRK: 50%
100% MRK50/50100% NAUBF
Portfolio after 10yr
$395.22M
Annual income
$374,131,820.88/yr
Blended yield
94.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NAUBF
No analyst data
Altman Z
0.3
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NAUBF buys
0
MRK buys
0
No recent congressional trades found for NAUBF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNAUBFMRK
Forward yield3.41%2.76%
Annual dividend / share$1.10$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$790.38M$56.8K
Annual income after 10y$748,253,843.62$9,798.13
Total dividends collected$787.31M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NAUBF vs MRK ($10,000, DRIP)

YearNAUBF PortfolioNAUBF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,383$682.50$11,206$366.19+$177.00NAUBF
2$13,631$1,452.07$12,650$502.35+$981.00NAUBF
3$17,836$3,250.39$14,407$694.19+$3.4KNAUBF
4$27,034$7,949.47$16,585$967.82+$10.4KNAUBF
5$51,448$22,521.50$19,342$1,363.89+$32.1KNAUBF
6$135,162$80,112.70$22,913$1,947.19+$112.2KNAUBF
7$538,024$393,400.60$27,662$2,823.89+$510.4KNAUBF
8$3,502,725$2,927,039.82$34,159$4,173.35+$3.47MNAUBF
9$39,366,731$35,618,814.65$43,337$6,308.80+$39.32MNAUBF
10$790,376,245$748,253,843.62$56,776$9,798.13+$790.32MNAUBF

NAUBF vs MRK: Complete Analysis 2026

NAUBFStock

National Australia Bank Limited provides financial services to individuals and businesses in Australia, New Zealand, and internationally. It operates through Business and Private Banking; Personal Banking; Corporate and Institutional Banking; New Zealand Banking; and Corporate Functions and Other segments. The company accepts transaction accounts, savings accounts, deposit accounts, and term deposits; and specialized accounts, such as foreign currency, business interest, statutory trust, cash maximiser, community free saver, farm management, and project bank accounts, as well as farm management deposits. National Australia Bank Limited also provides home loans; personal loans; business loans; vehicle and equipment finance; and trade and invoice finance, as well as business overdrafts and bank guarantees. In addition, the company offers insurance products consisting of car, home and content, landlord, travel, caravan and trailer, life, and business insurance products; and pension, superannuation, self-managed super funds, cash management, and financial planning and advisory services. Further, it provides investment products; credit, debit, and business cards; payments and merchant services; travel services; online and internet banking services; small business services; international and foreign exchange solutions; and industry specific banking services. National Australia Bank Limited was founded in 1834 and is based in Melbourne, Australia.

Full NAUBF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this NAUBF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NAUBF vs SCHDNAUBF vs JEPINAUBF vs ONAUBF vs KONAUBF vs MAINNAUBF vs JNJNAUBF vs ABBVNAUBF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.